Disease-free survival landmark analysis: a potential critical endpoint in triple-negative breast cancer

Taxanes plus carboplatin (TP) regimen may be an acceptable alternative adjuvant chemotherapy strategy in patients with triple-negative breast cancer (TNBC); however, the difference with the anthracycline-based regimen is yet to be clarified. Therefore, this study aimed to assess the difference betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Fangchao, Wei, Tong, Wang, Xue, Du, Feng, Yue, Jian, Yuan, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513960/
https://www.ncbi.nlm.nih.gov/pubmed/36167566
http://dx.doi.org/10.1186/s40164-022-00308-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513960/
https://www.ncbi.nlm.nih.gov/pubmed/36167566
http://dx.doi.org/10.1186/s40164-022-00308-8

Ejemplares similares